Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Medtech Money --- Episode 44: Sascha Alilovic, Managing Partner at SHS --- Growth Capital Focused on DACH: European Late-Stage Venture Perspective

Medtech Money --- Episode 44: Sascha Alilovic, Managing Partner at SHS --- Growth Capital Focused on DACH: European Late-Stage Venture Perspective

FromProject Medtech


Medtech Money --- Episode 44: Sascha Alilovic, Managing Partner at SHS --- Growth Capital Focused on DACH: European Late-Stage Venture Perspective

FromProject Medtech

ratings:
Length:
58 minutes
Released:
May 7, 2020
Format:
Podcast episode

Description


In this episode, Giovanni and Sascha discuss how he became the Managing Partner at SHS, where they focus from a stage of company and geographical area, the hardline of having revenue before they invest, the major differences of going public in the US and Europe for later stage companies, the affect of EU MDR on the region and innovation, their due diligence process, and more.
Sascha Alilovic LinkedIn
SHS Website
Giovanni Lauricella LinkedIn
Project Medtech LinkedIn
Project Medtech Website
Released:
May 7, 2020
Format:
Podcast episode

Titles in the series (100)

Join us as we sit down with leading experts in the Medtech Industry as they share success stories, advice, pitfalls, trends and innovations.